NEW YORK, Sept 21 (Thomson Reuters Foundation) - World leaders one year ago agreed on an ambitious set of global goals designed to tackle the world's most troubling problems such as extreme poverty and inequality by 2030 at the United Nations.

(Reuters) - Botox maker Allergan Plc, in its third acquisition this month, said it would pay up to $1.7 billion for Tobira Therapeutics Inc to get a leg up in the race to develop therapies for NASH, an incurable fatty liver disease closely linked to obesity.

CAIRO (Reuters) - An Egyptian court sentenced nine policemen to three months in prison on Tuesday for physically and verbally assaulting two doctors at a Cairo hospital in January, an incident that prompted strikes and a protest demanding justice.

(Reuters Health) - In a new study comparing a meditation retreat with just relaxing in the same locale, both options improved stress regulation, immune function and other cellular markers in the blood.

(Reuters) - Allergan Inc on Tuesday said it had paid $50 million for Akarna Therapeutics Ltd, a privately held company developing treatments for a incurable fatty liver disease called NASH.

Sept 20 (Reuters) - Wall Street ended little changed on Tuesday as healthcare gains countered declines in energy shares, a day before highly anticipated outcomes of monetary policy meetings in the United States and Japan.

(Reuters Health) - More than a fifth U.S. school districts lack comprehensive plans to respond to natural disasters, epidemic diseases or other emergencies, a new report finds.

NEW YORK, Sept 20 (Reuters) - U.S. government spending on Mylan Inc's EpiPen in the Medicare program for seniors and the disabled rose 1,151 percent from 2007 through 2014, while the number of EpiPen users grew 164 percent, the Kaiser Family Foundation said on Tuesday in an analysis.

(Reuters Health) - Infants who get a taste of eggs and peanuts starting when they’re as young as 4 months old may have a lower risk of developing allergies to those foods than babies who try them later, a research review suggests.